Tech Company Financing Transactions
BioMarck Pharmaceuticals Funding Round
Private investors participated in a $4 million funding round for BioMarck Pharmaceuticals. The financing round was announced on 9/4/2007.
Transaction Overview
Company Name
Announced On
9/4/2007
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The financing together with prior National
Institutes of Health grants is intended to provide sufficient funds to complete a Phase II, proof
of concept clinical study, says Allen F. Gant, Chairman and CEO.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2530 Meridian Pkwy. 300
Durham, NC 27713
USA
Durham, NC 27713
USA
Phone
Website
Email Address
Overview
BioMarck Pharmaceuticals develops new drugs for the treatment of pulmonary diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Brian Dickson
Chief Financial Officer
Michael Enright
Chief Scientific Officer
Indu Parikh
Browse more venture capital transactions:
Prev: 9/4/2007: SolFocus venture capital transaction
Next: 9/4/2007: Vivaty venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs